Kymera therapeutics, inc. (nasdaq:kymr) is among the 14 best booming stocks to buy right now. Its shares have gained over 28% in the last three months, with wall street anticipating a further uptick of …

Kymr analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. What is kymr's price target? According to 18 wall street analyst s that have issued a 1 year kymr price target, the average kymr price target is $117. 89, with the highest kymr stock price forecast at … Based on short-term price targets offered by 20 analysts, the average price target for kymera therapeutics, inc. Comes to $60. 70. The forecasts range from a low of $53. 00 to a high of $79. 00. This price target is based on 22 analysts offering 12 month price targets for kymera therapeutics in the last 3 months.

Comes to $60. 70. The forecasts range from a low of $53. 00 to a high of $79. 00. This price target is based on 22 analysts offering 12 month price targets for kymera therapeutics in the last 3 months. The average price target is $116. 30, with a high forecast of $138. 00 and a low forecast …